TW200638936A - Methods and dosage forms for reducing side effects of benzisoxazole derivatives - Google Patents

Methods and dosage forms for reducing side effects of benzisoxazole derivatives

Info

Publication number
TW200638936A
TW200638936A TW095103673A TW95103673A TW200638936A TW 200638936 A TW200638936 A TW 200638936A TW 095103673 A TW095103673 A TW 095103673A TW 95103673 A TW95103673 A TW 95103673A TW 200638936 A TW200638936 A TW 200638936A
Authority
TW
Taiwan
Prior art keywords
methods
dosage forms
side effects
benzisoxazole derivatives
reducing side
Prior art date
Application number
TW095103673A
Other languages
Chinese (zh)
Inventor
Gayatri Sathyan
Suneel Gupta
Noymi V Yam
Iran Reyes
Nipun Davar
Atul D Ayer
Julie Lee
Sonya Seroff
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/051,060 external-priority patent/US20050208132A1/en
Application filed by Alza Corp filed Critical Alza Corp
Publication of TW200638936A publication Critical patent/TW200638936A/en

Links

Abstract

Disclosed are dosage forms and methods comprising benzisoxazole derivatives. More particularly, disclosed are dosage forms, methods, and new uses of benzisoxazole derivatives that substantially reduce or substantially eliminate certain side effects of the benzisoxazole derivatives when dosed to a patient.
TW095103673A 2005-02-04 2006-02-03 Methods and dosage forms for reducing side effects of benzisoxazole derivatives TW200638936A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/051,060 US20050208132A1 (en) 2002-07-29 2005-02-04 Methods and dosage forms for reducing side effects of benzisozazole derivatives

Publications (1)

Publication Number Publication Date
TW200638936A true TW200638936A (en) 2006-11-16

Family

ID=38048170

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095103673A TW200638936A (en) 2005-02-04 2006-02-03 Methods and dosage forms for reducing side effects of benzisoxazole derivatives

Country Status (4)

Country Link
AR (1) AR053671A1 (en)
PE (1) PE20060997A1 (en)
TW (1) TW200638936A (en)
UY (1) UY29363A1 (en)

Also Published As

Publication number Publication date
UY29363A1 (en) 2006-08-31
AR053671A1 (en) 2007-05-16
PE20060997A1 (en) 2006-10-11

Similar Documents

Publication Publication Date Title
TW200740429A (en) Methods and dosage forms for reducing side effects of carbamate compounds
PH12017500930A1 (en) Hsp90 inhibitor combinations
TW200637522A (en) Skin treatment articles and methods
UA93903C2 (en) Tetrahydroisoquinoline derivatives to enhance memory function
MX2008011633A (en) Aminoquinolones as gsk-3 inhibitors.
MX2009009428A (en) Heterocyclic cyclopamine analogs and methods of use thereof.
MY148723A (en) Use of pinolenic acid for the treatment of obesity
EP2023926A4 (en) Pyridonecarboxamide derivatives useful in treating hyper-proliferative and angiogenesis disorders
MX349787B (en) Oral dosage forms including an antiplatelet agent and an acid inhibitor.
TW200700071A (en) Novel use
MX2020008616A (en) Sublingual fentanyl spray.
MX2007000224A (en) Use of substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines in the treatment of nausea and vomiting.
TW200718689A (en) 2-Amino-quinazolin-5-ones
TW200745124A (en) Azepinoindole derivatives as pharmaceutical agents
JO2756B1 (en) 4T 4-(4- Cyano-2-thioaryl)dihydropyrimidinones and use thereof
IL177483A0 (en) Means for transdermal administration of nicotine
MX2010006206A (en) 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases.
TW200716091A (en) New therapeutic combinations for the treatment or prevention of psychotic disorders
MX2010006204A (en) 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressine-dependent diseases.
WO2008052139A3 (en) Ultra low dose doxepin and methods of using the same to treat sleep disorders
HK1162502A1 (en) Cyanoaminoquinolones and tetrazoloaminoquinolones as gsk-3 inhibitors gsk-3
MX2011006725A (en) Combination of aurora kinase inhibitors and anti-cd20 antibodies.
WO2007136741A3 (en) N-desmethyl-doxepin and methods of using the same to treat sleep disorders
MX2009003239A (en) Long-term feed - elderly.
TW200801032A (en) Azaheterocyclyl derivatives of androstanes and androstenes as medicaments for cardiovascular disorders